title: [Etanercept in the treatment of rheumatoid arthritis. A case report].
abstract: Authors present a case of a patient affected by rheumatoid arthritis, non responder to the different DMARDs treatment; besides some of these treatments have even provoked relevant side effects. It has been attempted the use of biological therapy, using etanercept. After some months of this treatment with a high performance of the therapy and great subsidence of the disease, the appearance of a severe infection has compelled the interruption of the therapy, causing very slow recovery. Authors underline the relevant importance of a careful and constant observation of the patients under biological therapy, since it could be always possible the appearance of serious infections.
authors.affiliation: Sezione di Reumatologia, Dipartimento di Medicina Interna e Medicina Pubblica, Università degli Studi di Bari. m.damore@cimedoc.uniba.it
authors.forename: Massimo
authors.initials: M
authors.lastname: D'Amore
authors.forename: Giovanna
authors.initials: G
authors.lastname: Minenna
authors.forename: Angelo
authors.initials: A
authors.lastname: Nigro
authors.forename: Ivana
authors.initials: I
authors.lastname: Favia
authors.forename: Simona
authors.initials: S
authors.lastname: D'Amore
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept